TASKER SETH A (General Counsel) received a stock award from INFINITY PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/13/2020ACC: 0000899243-20-001083
Officer· General Counsel
Since Jan 2019
+466.04K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
466.04K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+53.54K
Price / share
—
Trade value
—
% of position
111.9%
1/10/2020
47.83K→101.36K
Total
Net shares
+53.54K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2020 | A · Award | +53.54K | — | — | 111.9% | 47.83K | 101.36K |
| Total | +53.54K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
412.50K shares
Shares
+412.50K
Strike price
1.25
Held after
412.50K
Exercisable
—
1/10/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock412.50K shares | 1/10/2020 | A · Award | +412.50K | 1.25 | — | 412.50K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned11.91K
Total
11.91K indirect11.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 11.91K | Indirect |
| Total | 11.91K | 11.91K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported